Daunorubicin reductase activity in human normal lymphocytes, myeloblasts and leukemic cell lines
- 1 October 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (10) , 1209-1213
- https://doi.org/10.1016/0277-5379(85)90017-3
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Multiple forms and inhibitors of uridine-cytidine kinase in neoplastic cellsInternational Journal of Biochemistry, 1982
- Daunorubicin reduction mediated by aldehyde and ketone reductasesXenobiotica, 1981
- Leukemic cell versus plasma levels of Daunorubicin and Daunorubicinol after infusion of Daunorubicin as free drug or the DNA complexCancer Chemotherapy and Pharmacology, 1980
- Determination of daunorubicin and its main metabolites in plasma, urine and leukaemic cells in patients with acute myeloblastic leukaemiaCancer Letters, 1980
- Mechanism of adriamycin resistance in a subline of mouse lymphoblastoma L5178Y cells.The Journal of Antibiotics, 1978
- Heterogeneity of anthracycline antibiotic carbonyl reductases in mammalian liversBiochemical Pharmacology, 1978
- Rat liver aldehyde reductaseBiochemical Pharmacology, 1977
- Transport and binding of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cellsBiochemical Pharmacology, 1977
- Cytoplasmic Aldo-Keto Reductases: A Class of Drug Metabolizing EnzymesScience, 1976
- Cellular pharmacodynamics of several anthracycline antibioticsJournal of Medicinal Chemistry, 1976